In a TriNetX US electronic health record analysis of 3.4 million matched pairs presented at the 2026 EASD meeting, younger people with type 2 diabetes showed substantially higher neurodiversity than matched peers without diabetes, with autism prevalence at ages 20-29 reaching 2.3% vs 0.6%. The presentation, Age at Diagnosis of Type 2 Diabetes and Neurodiversity: A Cross-Sectional Analysis, also found higher prevalence of ADHD, dyslexia, and dyscalculia among those diagnosed with type 2 diabetes earlier in life.

Why It Matters To Your Practice

• NPs and PAs are often the first clinicians to spot when a "nonadherent" patient may actually be navigating ADHD, autism, dyslexia, or other neurodiverse needs.

• This is frontline medicine: your communication style, visit structure, and follow-up plan can directly determine whether care is accessible or overwhelming.

• For younger adults with Diabetes mellitus (DM) type 2, neurodiversity may be an important hidden factor behind missed appointments, difficulty with self-management, or trouble navigating complex care settings.

Clinical Benefits

• Consider simple accommodations: clearer instructions, shorter action lists, written summaries, visual aids, and reduced sensory overload when possible.

• Screen your workflow for friction points, including portal messages, medication teaching, glucose-monitoring instructions, and referral handoffs.

• Recognizing neurodiversity early may improve engagement, trust, and diabetes self-management — and you are uniquely positioned to make that recognition count.

Managing Risks

• Do not overinterpret the findings: the study does not suggest most neurodivergent people will develop type 2 diabetes.

• This was a cross-sectional EHR analysis, so it shows association, not causation, and coding variability may affect prevalence estimates.

• Keep an eye out for care barriers that can worsen outcomes indirectly, including communication mismatches, overstimulating clinic environments, and overly complicated treatment plans.

The Bottom Line

• You are not practicing "adjacent" to the diagnostic process — you are leading it where it matters most: at the point of access, continuity, and behavior change.

• For younger patients with type 2 diabetes, tailoring care for possible neurodiverse needs is practical, equitable, and likely to improve real-world engagement.

• Bottom line: when you adapt care to how patients actually process information and navigate healthcare, you are doing the high-value clinical work that moves outcomes.